{
    "0": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1": "Non-responsive Error",
    "2": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3": "Non-responsive Error",
    "4": "Non-responsive Error",
    "5": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7": "Non-responsive Error",
    "8": "Non-responsive Error",
    "10": "Non-responsive Error",
    "12": "Non-responsive Error",
    "14": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "15": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "16": "Non-responsive Error",
    "17": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "18": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "20": "Non-responsive Error",
    "24": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "28": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "29": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "30": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "31": "Non-responsive Error",
    "32": "Non-responsive Error",
    "33": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "34": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "35": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "36": "Non-responsive Error",
    "37": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "38": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "39": "Non-responsive Error",
    "40": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "41": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "42": "Non-responsive Error",
    "43": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "45": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "48": "Non-responsive Error",
    "49": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "50": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "51": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "52": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "53": "Non-responsive Error",
    "55": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "57": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "59": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "60": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "61": "Non-responsive Error",
    "62": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "64": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "65": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "66": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "67": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "68": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "69": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "70": "Non-responsive Error",
    "71": "Non-responsive Error",
    "72": "Non-responsive Error",
    "74": "Non-responsive Error",
    "76": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "78": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "80": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "85": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "88": "Non-responsive Error",
    "89": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "91": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "92": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "93": "Non-responsive Error",
    "95": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "96": "Non-responsive Error",
    "97": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "98": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "99": "Non-responsive Error",
    "103": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "106": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "107": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "109": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "110": "Non-responsive Error",
    "111": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "112": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "117": "Non-responsive Error",
    "118": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "120": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "123": "Non-responsive Error",
    "124": "Non-responsive Error",
    "125": "Non-responsive Error",
    "126": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "128": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "130": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "132": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "133": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "134": "Non-responsive Error",
    "135": "Non-responsive Error",
    "140": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "141": "Non-responsive Error",
    "142": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "143": "Non-responsive Error",
    "145": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "146": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "147": "Non-responsive Error",
    "148": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "149": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "150": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "152": "Non-responsive Error",
    "153": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "157": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have metastatic lesions based on the information in the patient note.",
    "160": "Non-responsive Error",
    "163": "Non-responsive Error",
    "164": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "165": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "166": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "169": "Non-responsive Error",
    "170": "Non-responsive Error",
    "171": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "172": "Non-responsive Error",
    "173": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "174": "Non-responsive Error",
    "175": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "176": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "178": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "180": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "183": "Non-responsive Error",
    "184": "Non-responsive Error",
    "186": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "188": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "189": "Non-responsive Error",
    "190": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "191": "Non-responsive Error",
    "193": "Non-responsive Error",
    "194": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "195": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "196": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "197": "Non-responsive Error",
    "198": "Non-responsive Error",
    "200": "Non-responsive Error",
    "203": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "205": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "206": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "207": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "208": "Non-responsive Error",
    "209": "Non-responsive Error",
    "211": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "213": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "214": "Non-responsive Error",
    "215": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "218": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "221": "Non-responsive Error",
    "222": "Non-responsive Error",
    "224": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "225": "Non-responsive Error",
    "226": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "227": "Non-responsive Error",
    "230": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "231": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "234": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "235": "Non-responsive Error",
    "237": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "239": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "240": "Non-responsive Error",
    "242": "Non-responsive Error",
    "243": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "244": "Non-responsive Error",
    "245": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "246": "Non-responsive Error",
    "248": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "250": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "251": "Non-responsive Error",
    "252": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "253": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "255": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "256": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "257": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "260": "Non-responsive Error",
    "263": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "266": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "268": "Non-responsive Error",
    "269": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "270": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "272": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "274": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "275": "Non-responsive Error",
    "278": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "280": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "282": "Non-responsive Error",
    "283": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "284": "Non-responsive Error",
    "286": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "287": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "288": "Non-responsive Error",
    "290": "Non-responsive Error",
    "291": "Non-responsive Error",
    "293": "Non-responsive Error",
    "294": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "295": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "296": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "297": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "298": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "299": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "301": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "304": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "305": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "308": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "309": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "313": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "314": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "315": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "316": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "318": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "319": "Non-responsive Error",
    "321": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "322": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "323": "Non-responsive Error",
    "324": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "325": "Non-responsive Error",
    "327": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "330": "Non-responsive Error",
    "331": "Non-responsive Error",
    "332": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "334": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "335": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "337": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "339": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "340": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "341": "Non-responsive Error",
    "342": "Non-responsive Error",
    "343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "344": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "347": "Non-responsive Error",
    "349": "Non-responsive Error",
    "350": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "353": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "354": "Non-responsive Error",
    "355": "Non-responsive Error",
    "356": "Non-responsive Error",
    "357": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "358": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "359": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "360": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "363": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "364": "Non-responsive Error",
    "365": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "366": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "370": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "371": "Non-responsive Error",
    "374": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "375": "Non-responsive Error",
    "376": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "378": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "384": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "387": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "390": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "391": "Non-responsive Error",
    "394": "Non-responsive Error",
    "396": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "398": "Non-responsive Error",
    "401": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "403": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "405": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "408": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "409": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "410": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "412": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "415": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "416": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "419": "Non-responsive Error",
    "424": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "425": "Non-responsive Error",
    "429": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "430": "Non-responsive Error",
    "432": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "438": "Non-responsive Error",
    "439": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "440": "Non-responsive Error",
    "441": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "442": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "444": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "446": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "448": "Non-responsive Error",
    "451": "Non-responsive Error",
    "452": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "453": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "454": "Non-responsive Error",
    "456": "Non-responsive Error",
    "457": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "458": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "460": "Non-responsive Error",
    "461": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "462": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "463": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "467": "Non-responsive Error",
    "469": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "472": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "474": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "475": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "476": "Non-responsive Error",
    "477": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "478": "Non-responsive Error",
    "480": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "481": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "483": "Non-responsive Error",
    "485": "Non-responsive Error",
    "486": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "487": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "488": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "489": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "491": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "494": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "495": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "496": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "498": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "499": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "500": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "503": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "504": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "505": "Non-responsive Error",
    "506": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "507": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "508": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "509": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "512": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "514": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "516": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "521": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "523": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "524": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "527": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "528": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "529": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "530": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "531": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "533": "Non-responsive Error",
    "535": "Non-responsive Error",
    "537": "Non-responsive Error",
    "539": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "540": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "541": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "542": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "544": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "545": "Non-responsive Error",
    "546": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "547": "Non-responsive Error",
    "548": "Non-responsive Error",
    "550": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "551": "Non-responsive Error",
    "553": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "554": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "555": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "556": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "557": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "558": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "559": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "561": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "562": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "564": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "565": "Non-responsive Error",
    "569": "Non-responsive Error",
    "571": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "572": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "574": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "575": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "577": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "578": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "579": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "580": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "581": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "582": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "583": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "584": "Non-responsive Error",
    "585": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "586": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "587": "Non-responsive Error",
    "588": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "589": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "590": "Non-responsive Error",
    "591": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "593": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "594": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "595": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "596": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "598": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "599": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "601": "Non-responsive Error",
    "602": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "605": "Non-responsive Error",
    "606": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "607": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "608": "Non-responsive Error",
    "609": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "610": "Non-responsive Error",
    "611": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "612": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "613": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "615": "Non-responsive Error",
    "621": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "622": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "624": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "625": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "626": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "627": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "628": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "629": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "631": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "632": "Non-responsive Error",
    "633": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "635": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "637": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "638": "Non-responsive Error",
    "639": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "640": "Non-responsive Error",
    "641": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "642": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "643": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "644": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "646": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "647": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "648": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "649": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "651": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "652": "Non-responsive Error",
    "654": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "656": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "657": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "658": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "661": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "662": "Non-responsive Error",
    "663": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "664": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "668": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "669": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "670": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "672": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "673": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "674": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "675": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "677": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "680": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "681": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "682": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "684": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "685": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "686": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "689": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "690": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "691": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "692": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "694": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "695": "Non-responsive Error",
    "697": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "698": "Non-responsive Error",
    "702": "Non-responsive Error",
    "703": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "704": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "705": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "707": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "708": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "710": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "711": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "713": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "716": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "717": "Non-responsive Error",
    "718": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "720": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "721": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "722": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "725": "Non-responsive Error",
    "726": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "727": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "730": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "733": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "734": "Non-responsive Error",
    "735": "Non-responsive Error",
    "736": "Non-responsive Error",
    "738": "Non-responsive Error",
    "740": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "741": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "742": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "743": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "745": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "747": "Non-responsive Error",
    "749": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "752": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "753": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "755": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "758": "Non-responsive Error",
    "759": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "761": "Non-responsive Error",
    "762": "Non-responsive Error",
    "763": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "766": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "767": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "769": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "770": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "772": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "775": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "777": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "778": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "779": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "780": "Non-responsive Error",
    "781": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "782": "Non-responsive Error",
    "783": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "784": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "785": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "786": "Non-responsive Error",
    "787": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "788": "Non-responsive Error",
    "790": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "793": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "794": "Non-responsive Error",
    "796": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "797": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "798": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "799": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "801": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "803": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "804": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "806": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "807": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "809": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "810": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "811": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "812": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "813": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "815": "Non-responsive Error",
    "816": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "817": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "818": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "820": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "822": "Non-responsive Error",
    "823": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "824": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "825": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "827": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "828": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "830": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "831": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "832": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "834": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "835": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "837": "Non-responsive Error",
    "838": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "840": "Non-responsive Error",
    "841": "Non-responsive Error",
    "843": "Non-responsive Error",
    "844": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "846": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "849": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "850": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "851": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "852": "Non-responsive Error",
    "853": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "854": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "855": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "857": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "858": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "859": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "860": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "861": "Non-responsive Error",
    "862": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "863": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "864": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "866": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "869": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "870": "Non-responsive Error",
    "871": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "872": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "873": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "874": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "875": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "876": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "880": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "881": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "882": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "883": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "884": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "885": "Non-responsive Error",
    "888": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "890": "Non-responsive Error",
    "892": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "894": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "895": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "897": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "898": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "899": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "900": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "901": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "903": "Non-responsive Error",
    "904": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "907": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "908": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "910": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "914": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "915": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "916": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "917": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "918": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "920": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "921": "Non-responsive Error",
    "923": "Non-responsive Error",
    "924": "Non-responsive Error",
    "925": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "926": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "927": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "928": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "929": "Non-responsive Error",
    "931": "Non-responsive Error",
    "932": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "933": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "935": "Non-responsive Error",
    "936": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "937": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "938": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "939": "Non-responsive Error",
    "940": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "941": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "944": "Non-responsive Error",
    "945": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "946": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "947": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "950": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "952": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "953": "Non-responsive Error",
    "954": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "955": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "956": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "957": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "959": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "960": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "961": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "966": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "968": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "970": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "972": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "974": "Non-responsive Error",
    "976": "Non-responsive Error",
    "978": "Non-responsive Error",
    "979": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "981": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "982": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "983": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "986": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "989": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "990": "Non-responsive Error",
    "991": "Non-responsive Error",
    "992": "Non-responsive Error",
    "993": "Non-responsive Error",
    "994": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "996": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "998": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1002": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1003": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1005": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1006": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1008": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1010": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1015": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1016": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1018": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1019": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1025": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1029": "Non-responsive Error",
    "1031": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1033": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1034": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1035": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1037": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1038": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1040": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1041": "Non-responsive Error",
    "1043": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1044": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1045": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1047": "Non-responsive Error",
    "1048": "Non-responsive Error",
    "1049": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1051": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1052": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1056": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1059": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1061": "Non-responsive Error",
    "1062": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1064": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1065": "Non-responsive Error",
    "1067": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1068": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1069": "Non-responsive Error",
    "1070": "Non-responsive Error",
    "1073": "Non-responsive Error",
    "1078": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1079": "Non-responsive Error",
    "1080": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1081": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1083": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1084": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1085": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1086": "Non-responsive Error",
    "1088": "Non-responsive Error",
    "1096": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1097": "Non-responsive Error",
    "1098": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1099": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1102": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1103": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1104": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1105": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1106": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1108": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1109": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1110": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1112": "Non-responsive Error",
    "1113": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1115": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1118": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1119": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1120": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1122": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1123": "Non-responsive Error",
    "1125": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1126": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1127": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1130": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1131": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1132": "Non-responsive Error",
    "1136": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1137": "Non-responsive Error",
    "1138": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1139": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1142": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1143": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1144": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1151": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1153": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1155": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1157": "Non-responsive Error",
    "1159": "Non-responsive Error",
    "1160": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1164": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1165": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1167": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1168": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1169": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1170": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1171": "Non-responsive Error",
    "1173": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1175": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1177": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1178": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1180": "Non-responsive Error",
    "1181": "Non-responsive Error",
    "1182": "Non-responsive Error",
    "1183": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1184": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1187": "Non-responsive Error",
    "1189": "Non-responsive Error",
    "1190": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1191": "Non-responsive Error",
    "1194": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1197": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1198": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1201": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1202": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1203": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1207": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1212": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1214": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1215": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1217": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1219": "Non-responsive Error",
    "1224": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1225": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1228": "Non-responsive Error",
    "1232": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1234": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "1238": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1241": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1242": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1243": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1244": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1245": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1248": "Non-responsive Error",
    "1249": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1250": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1251": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1252": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1259": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1263": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1264": "Non-responsive Error",
    "1265": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1274": "Non-responsive Error",
    "1275": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could indicate the presence of distant metastases, which is an exclusion criterion for the trial (\"Advanced local disease or distant metastases (stage III or IV)\").\n\nIf the metastatic lesions mentioned in the patient note refer to distant metastases, then the patient would be ineligible for the trial.\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible according to the exclusion criteria.",
    "1278": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1281": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1282": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1283": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1284": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1286": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1287": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1288": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1289": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1292": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1295": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1297": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1299": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1300": "Non-responsive Error",
    "1308": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1310": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1311": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1312": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1313": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1314": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1316": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1317": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1319": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1320": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1321": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1322": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1325": "Non-responsive Error",
    "1326": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1327": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1328": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1329": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1331": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1332": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1334": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1337": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1339": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1340": "Non-responsive Error",
    "1342": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1345": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1352": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1354": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1357": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1360": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1362": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1363": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1366": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1368": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1372": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1373": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1374": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1375": "Non-responsive Error",
    "1377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1379": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1381": "Non-responsive Error",
    "1386": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1387": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1388": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1389": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1390": "Non-responsive Error",
    "1391": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1394": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1398": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1400": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1401": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1402": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1403": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1408": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1411": "Non-responsive Error",
    "1413": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1414": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1415": "Non-responsive Error",
    "1417": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1419": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1421": "Non-responsive Error",
    "1423": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1425": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1426": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1427": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1428": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1430": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1433": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1440": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1441": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1443": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1444": "Non-responsive Error",
    "1446": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1448": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1449": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1450": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1451": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1452": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1456": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1458": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1459": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1460": "Non-responsive Error",
    "1462": "Non-responsive Error",
    "1463": "Non-responsive Error",
    "1465": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1466": "Non-responsive Error",
    "1468": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1469": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1470": "Non-responsive Error",
    "1471": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1473": "Non-responsive Error",
    "1474": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1475": "Non-responsive Error",
    "1480": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1481": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1482": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1483": "Non-responsive Error",
    "1484": "Non-responsive Error",
    "1486": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1488": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1490": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1491": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1493": "Non-responsive Error",
    "1495": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1497": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1504": "Non-responsive Error",
    "1506": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1507": "Non-responsive Error",
    "1508": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1509": "Non-responsive Error",
    "1513": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1514": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1516": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1517": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1519": "Non-responsive Error",
    "1520": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1522": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1523": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1524": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1527": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1528": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1529": "Non-responsive Error",
    "1530": "Non-responsive Error",
    "1531": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1532": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1533": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1535": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1536": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1538": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1539": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1541": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1542": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1544": "Non-responsive Error",
    "1545": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1546": "Non-responsive Error",
    "1548": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1549": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1550": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1554": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1555": "Non-responsive Error",
    "1556": "Non-responsive Error",
    "1557": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1558": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1559": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1560": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1561": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1562": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1564": "Non-responsive Error",
    "1565": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1567": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1570": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1571": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1572": "Non-responsive Error",
    "1573": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1574": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1577": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1578": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1582": "Non-responsive Error",
    "1585": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1587": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1588": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1589": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1590": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1591": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1592": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1593": "Non-responsive Error",
    "1594": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1595": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1596": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1598": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1599": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1600": "Non-responsive Error",
    "1601": "Non-responsive Error",
    "1602": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1603": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1604": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1606": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1607": "Non-responsive Error",
    "1610": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1611": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1612": "Non-responsive Error",
    "1613": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1614": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1615": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1616": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "1617": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1618": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1619": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1622": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1623": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1624": "Non-responsive Error",
    "1625": "Non-responsive Error",
    "1626": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1628": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1630": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1633": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1634": "Non-responsive Error",
    "1635": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1636": "Non-responsive Error",
    "1637": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1638": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1639": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1640": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1641": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1642": "Non-responsive Error",
    "1643": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1644": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1645": "Non-responsive Error",
    "1646": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1647": "Non-responsive Error",
    "1649": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1651": "Non-responsive Error",
    "1653": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1654": "Non-responsive Error",
    "1656": "Non-responsive Error",
    "1657": "Non-responsive Error",
    "1660": "Non-responsive Error",
    "1662": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1663": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1665": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1666": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1667": "Non-responsive Error",
    "1669": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1670": "Non-responsive Error",
    "1672": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1673": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1675": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1676": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1677": "Non-responsive Error",
    "1678": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1679": "Non-responsive Error",
    "1680": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1681": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1682": "Non-responsive Error",
    "1685": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1686": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1688": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1690": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1691": "Non-responsive Error",
    "1692": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1693": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1695": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1699": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1700": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1705": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1706": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1707": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1708": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1710": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1711": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1713": "Non-responsive Error",
    "1714": "Non-responsive Error",
    "1715": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1716": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1718": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1720": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1721": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1722": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1723": "Non-responsive Error",
    "1724": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1726": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1727": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1728": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1729": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1730": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1731": "Non-responsive Error",
    "1732": "Non-responsive Error",
    "1733": "Non-responsive Error",
    "1734": "Non-responsive Error",
    "1735": "Non-responsive Error",
    "1736": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1737": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1739": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1742": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1743": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1744": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1747": "Non-responsive Error",
    "1748": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1749": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1750": "Non-responsive Error",
    "1752": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1753": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1754": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1755": "Non-responsive Error",
    "1758": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1759": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1760": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1762": "Non-responsive Error",
    "1763": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1765": "Non-responsive Error",
    "1766": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1767": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1768": "Non-responsive Error",
    "1769": "Non-responsive Error",
    "1770": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1772": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1773": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1774": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1775": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1777": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1778": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1779": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1780": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1781": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1782": "Non-responsive Error",
    "1783": "Non-responsive Error",
    "1784": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1785": "Non-responsive Error",
    "1786": "Non-responsive Error",
    "1789": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1790": "Non-responsive Error",
    "1793": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1794": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1795": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1796": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1797": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1798": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1800": "Non-responsive Error",
    "1801": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1803": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1804": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1805": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1806": "Non-responsive Error",
    "1808": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1812": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1813": "Non-responsive Error",
    "1815": "Non-responsive Error",
    "1816": "Non-responsive Error",
    "1817": "Non-responsive Error",
    "1818": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1819": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1821": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1822": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1823": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1825": "Non-responsive Error",
    "1827": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1828": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1829": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1830": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1833": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1834": "Non-responsive Error",
    "1835": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1836": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1837": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1838": "Non-responsive Error",
    "1839": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1840": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1841": "Non-responsive Error",
    "1842": "Non-responsive Error",
    "1843": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1844": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1845": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1846": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1847": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1849": "Non-responsive Error",
    "1850": "Non-responsive Error",
    "1851": "Non-responsive Error",
    "1852": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1853": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1854": "Non-responsive Error",
    "1855": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1857": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1858": "Non-responsive Error",
    "1860": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1861": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1862": "Non-responsive Error",
    "1863": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1864": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1865": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1866": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1867": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1869": "Non-responsive Error",
    "1870": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1871": "Non-responsive Error",
    "1873": "Non-responsive Error",
    "1874": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1875": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1876": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "1877": "Non-responsive Error",
    "1878": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1879": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1881": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1882": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1883": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1884": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1885": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1886": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1887": "Non-responsive Error",
    "1889": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1890": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1891": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1892": "Non-responsive Error",
    "1894": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1895": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1896": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1898": "Non-responsive Error",
    "1899": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1901": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1903": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1906": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1907": "Non-responsive Error",
    "1908": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1910": "Non-responsive Error",
    "1912": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1916": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1918": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1919": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1920": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1921": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1922": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1924": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1928": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1930": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1933": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1934": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1935": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1939": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1941": "Non-responsive Error",
    "1943": "Non-responsive Error",
    "1944": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1945": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1946": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1947": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1948": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1951": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1952": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1953": "Non-responsive Error",
    "1954": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1955": "Non-responsive Error",
    "1956": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1957": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1958": "Non-responsive Error",
    "1960": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1963": "Non-responsive Error",
    "1965": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1968": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1969": "Non-responsive Error",
    "1970": "Non-responsive Error",
    "1971": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1972": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1973": "Non-responsive Error",
    "1974": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1975": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1977": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1978": "Non-responsive Error",
    "1979": "Non-responsive Error",
    "1982": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1985": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1986": "Non-responsive Error",
    "1988": "Non-responsive Error",
    "1990": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1991": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1992": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1995": "Non-responsive Error",
    "1996": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1997": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "1998": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "1999": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2000": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2001": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2002": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2004": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2007": "Non-responsive Error",
    "2008": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2010": "Non-responsive Error",
    "2013": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2015": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2017": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2020": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2024": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2025": "Non-responsive Error",
    "2026": "Non-responsive Error",
    "2027": "Non-responsive Error",
    "2028": "Non-responsive Error",
    "2032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2036": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2037": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2040": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2042": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "2045": "Non-responsive Error",
    "2049": "Non-responsive Error",
    "2052": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2056": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2059": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2061": "Non-responsive Error",
    "2062": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2067": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2068": "Non-responsive Error",
    "2070": "Non-responsive Error",
    "2077": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2080": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2084": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "2085": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2086": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2088": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "2089": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2091": "Non-responsive Error",
    "2093": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2100": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2103": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2111": "Non-responsive Error",
    "2113": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2120": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2121": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2127": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2128": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2129": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2132": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2136": "Non-responsive Error",
    "2139": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2140": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2141": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2145": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2147": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2148": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2149": "Non-responsive Error",
    "2152": "Non-responsive Error",
    "2156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2158": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2162": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2163": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2166": "Non-responsive Error",
    "2169": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2170": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2172": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2173": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2174": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2177": "Non-responsive Error",
    "2179": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2182": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2184": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2185": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2186": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2187": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2188": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2192": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2193": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2196": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2197": "Non-responsive Error",
    "2201": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2203": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2204": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2205": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2208": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2209": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2211": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2213": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2218": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2219": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2221": "Non-responsive Error",
    "2224": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2225": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2228": "Non-responsive Error",
    "2229": "Non-responsive Error",
    "2233": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2238": "Non-responsive Error",
    "2239": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2243": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2245": "Non-responsive Error",
    "2246": "Non-responsive Error",
    "2248": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2249": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2250": "Non-responsive Error",
    "2251": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2253": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2254": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2255": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2256": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2259": "Non-responsive Error",
    "2261": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2262": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2264": "Non-responsive Error",
    "2265": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2267": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2271": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2275": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2277": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2279": "Non-responsive Error",
    "2283": "Non-responsive Error",
    "2289": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2293": "Non-responsive Error",
    "2297": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2298": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2300": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2303": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2306": "Non-responsive Error",
    "2307": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2309": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2310": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2311": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2320": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2321": "Non-responsive Error",
    "2322": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2323": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2327": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2330": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2331": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2334": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2337": "Non-responsive Error",
    "2340": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2342": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2344": "Non-responsive Error",
    "2345": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2348": "Non-responsive Error",
    "2350": "Non-responsive Error",
    "2352": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2353": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2356": "Non-responsive Error",
    "2358": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2360": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2362": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2368": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2369": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2371": "Non-responsive Error",
    "2372": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2375": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2385": "Non-responsive Error",
    "2388": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2389": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2391": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2396": "Non-responsive Error",
    "2398": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2402": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2407": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2408": "Non-responsive Error",
    "2409": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2412": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2416": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2419": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2420": "Non-responsive Error",
    "2423": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "2424": "Non-responsive Error",
    "2426": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2427": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2428": "Non-responsive Error",
    "2432": "Non-responsive Error",
    "2435": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2442": "Non-responsive Error",
    "2445": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2456": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2459": "Non-responsive Error",
    "2461": "Non-responsive Error",
    "2463": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2468": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2469": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2470": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2471": "Non-responsive Error",
    "2472": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2473": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2474": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2479": "Non-responsive Error",
    "2482": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2484": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2485": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2486": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2489": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2495": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2501": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2504": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2505": "Non-responsive Error",
    "2507": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2508": "Non-responsive Error",
    "2511": "Non-responsive Error",
    "2512": "Non-responsive Error",
    "2513": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2515": "Non-responsive Error",
    "2521": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2523": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2524": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2531": "Non-responsive Error",
    "2541": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2544": "Non-responsive Error",
    "2547": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2549": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2553": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2555": "Non-responsive Error",
    "2556": "Non-responsive Error",
    "2559": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2561": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2563": "Non-responsive Error",
    "2564": "Non-responsive Error",
    "2565": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2567": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2568": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2569": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2570": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2571": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2572": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2573": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2574": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2577": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2578": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2580": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2581": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2582": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2585": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2589": "Non-responsive Error",
    "2591": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2593": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2596": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2597": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2599": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2600": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2601": "Non-responsive Error",
    "2602": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2604": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2606": "Non-responsive Error",
    "2608": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2609": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2610": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2613": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2615": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2616": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2632": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2633": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2636": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2639": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2659": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "2664": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2668": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2669": "Non-responsive Error",
    "2671": "Non-responsive Error",
    "2672": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2673": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2675": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2676": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2679": "Non-responsive Error",
    "2684": "Non-responsive Error",
    "2685": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2686": "Non-responsive Error",
    "2689": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2691": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "2694": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2696": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2697": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "2701": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2707": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2714": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2718": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2720": "Non-responsive Error",
    "2722": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2727": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2728": "Non-responsive Error",
    "2729": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2735": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2740": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2743": "Non-responsive Error",
    "2745": "Non-responsive Error",
    "2750": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2752": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2757": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2758": "Non-responsive Error",
    "2760": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2762": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2763": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2764": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2765": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2767": "Non-responsive Error",
    "2769": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2772": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2774": "Non-responsive Error",
    "2784": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2787": "Non-responsive Error",
    "2788": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2791": "Non-responsive Error",
    "2795": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2801": "Non-responsive Error",
    "2802": "Non-responsive Error",
    "2807": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2814": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2815": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2819": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2820": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2821": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2822": "Non-responsive Error",
    "2825": "Non-responsive Error",
    "2829": "Non-responsive Error",
    "2830": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2832": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2833": "Non-responsive Error",
    "2834": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2835": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2841": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2843": "Non-responsive Error",
    "2845": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2847": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2856": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2857": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2858": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2862": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2865": "Non-responsive Error",
    "2867": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2876": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2877": "Non-responsive Error",
    "2879": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2883": "Non-responsive Error",
    "2884": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2887": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2888": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2889": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2890": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2893": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2900": "Non-responsive Error",
    "2902": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2903": "Non-responsive Error",
    "2905": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2908": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2909": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2912": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2914": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2916": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2917": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2919": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2920": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "2924": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2927": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2929": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "2930": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2933": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2936": "Non-responsive Error",
    "2942": "Non-responsive Error",
    "2948": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2950": "Non-responsive Error",
    "2961": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2969": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2972": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2973": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2984": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2986": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2991": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "2994": "Non-responsive Error",
    "3001": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3002": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3004": "Non-responsive Error",
    "3006": "Non-responsive Error",
    "3007": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3008": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3011": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3012": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3016": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3018": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3025": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3027": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3031": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3034": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3041": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3042": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3043": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3047": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3049": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "3051": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3053": "Non-responsive Error",
    "3055": "Non-responsive Error",
    "3057": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3066": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3067": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3070": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3071": "Non-responsive Error",
    "3072": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3073": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3074": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3082": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3084": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3085": "Non-responsive Error",
    "3086": "Non-responsive Error",
    "3087": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3088": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3089": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3091": "Non-responsive Error",
    "3093": "Non-responsive Error",
    "3097": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3098": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3102": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3103": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3104": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3106": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3107": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3109": "Non-responsive Error",
    "3110": "Non-responsive Error",
    "3112": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "3116": "Non-responsive Error",
    "3118": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3119": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3120": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3121": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3122": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3123": "Non-responsive Error",
    "3124": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3125": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3126": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3128": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3129": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3132": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3134": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3137": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3139": "Non-responsive Error",
    "3140": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3141": "Non-responsive Error",
    "3142": "Non-responsive Error",
    "3143": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3144": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3146": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3150": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3156": "Non-responsive Error",
    "3157": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3160": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3161": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3162": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3165": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3168": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3169": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3170": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3172": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3174": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3176": "Non-responsive Error",
    "3177": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3180": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3183": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3184": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "3186": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3187": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3190": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3192": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3193": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3194": "Non-responsive Error",
    "3195": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3196": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3198": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3200": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3201": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3202": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3204": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3206": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3208": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "3209": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3210": "Non-responsive Error",
    "3212": "Non-responsive Error",
    "3213": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3214": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3215": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3217": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3219": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3222": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3223": "Non-responsive Error",
    "3225": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3229": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3230": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3231": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3232": "Non-responsive Error",
    "3234": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3235": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3236": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3238": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3239": "Non-responsive Error",
    "3245": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3246": "Non-responsive Error",
    "3253": "Non-responsive Error",
    "3254": "Non-responsive Error",
    "3255": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3256": "Non-responsive Error",
    "3258": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3259": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3260": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3262": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3263": "Non-responsive Error",
    "3264": "Non-responsive Error",
    "3270": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3276": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3277": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3278": "Non-responsive Error",
    "3279": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3280": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3281": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3282": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3284": "Non-responsive Error",
    "3285": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3288": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3289": "Non-responsive Error",
    "3292": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3293": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3294": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3300": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3302": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3303": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3304": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3305": "Non-responsive Error",
    "3306": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3308": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3309": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3310": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3312": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3314": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3315": "Non-responsive Error",
    "3316": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3318": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3319": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3320": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3321": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3322": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3326": "Non-responsive Error",
    "3329": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3331": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3335": "Non-responsive Error",
    "3336": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3337": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3340": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3341": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3342": "Non-responsive Error",
    "3343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3344": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3345": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3347": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3348": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3349": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3350": "Non-responsive Error",
    "3351": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3352": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3353": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3357": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3359": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3361": "Non-responsive Error",
    "3365": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3366": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3367": "Non-responsive Error",
    "3368": "Non-responsive Error",
    "3370": "Non-responsive Error",
    "3371": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3373": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3374": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3376": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3379": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3380": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3381": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3382": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3383": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3384": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3385": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3386": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3387": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3389": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3392": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3393": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3394": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3396": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3399": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3401": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3403": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3410": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3412": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3416": "Non-responsive Error",
    "3417": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3419": "Non-responsive Error",
    "3423": "Non-responsive Error",
    "3425": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3427": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3432": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3433": "Non-responsive Error",
    "3441": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3442": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3443": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3447": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3448": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3449": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3450": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3452": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3455": "Non-responsive Error",
    "3457": "Non-responsive Error",
    "3458": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "3460": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3461": "Non-responsive Error",
    "3462": "Non-responsive Error",
    "3464": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3467": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3470": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3472": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3473": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3475": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3476": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3478": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3481": "Non-responsive Error",
    "3484": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3486": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have metastatic lesions based on the information in the patient note.",
    "3492": "Non-responsive Error",
    "3493": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3496": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3498": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3499": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3501": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3505": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3506": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3507": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3508": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3509": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3511": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3513": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3514": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3516": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3517": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3518": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3519": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3520": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3521": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3522": "Non-responsive Error",
    "3523": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3524": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3526": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3528": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3529": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3530": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3531": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3532": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3533": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3534": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3536": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3540": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3541": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3542": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3543": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3544": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3545": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3546": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3548": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3551": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3554": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3555": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3557": "Non-responsive Error",
    "3558": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3561": "Non-responsive Error",
    "3562": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3563": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3569": "Non-responsive Error",
    "3575": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3582": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3583": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3584": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3585": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3586": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3587": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3588": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3590": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3592": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3594": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3602": "Non-responsive Error",
    "3603": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3604": "Non-responsive Error",
    "3605": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3608": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3614": "Non-responsive Error",
    "3616": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3617": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3618": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3619": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3621": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3625": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3627": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3628": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3635": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3637": "Non-responsive Error",
    "3642": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3645": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3647": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3649": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3651": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3653": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3657": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3658": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3659": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3662": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3663": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3665": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3668": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3669": "Non-responsive Error",
    "3670": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3672": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3676": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3678": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3680": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3681": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3684": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3686": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3689": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3690": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3691": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3695": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3698": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3702": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3703": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3705": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3707": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3709": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3711": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3713": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3715": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3716": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3717": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3719": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3720": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3721": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3722": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3724": "Non-responsive Error",
    "3725": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3727": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3728": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3729": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3730": "Non-responsive Error",
    "3731": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3732": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3733": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3734": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3736": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3740": "Non-responsive Error",
    "3741": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3748": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3751": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3752": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3753": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3755": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3756": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3758": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3762": "Non-responsive Error",
    "3764": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3765": "Non-responsive Error",
    "3767": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3771": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3773": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3774": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3776": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3778": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3779": "Non-responsive Error",
    "3785": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3787": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3789": "Non-responsive Error",
    "3790": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3794": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3796": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "3797": "Non-responsive Error",
    "3800": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3801": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3802": "Non-responsive Error",
    "3804": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3808": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3810": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3811": "Non-responsive Error",
    "3812": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3819": "Non-responsive Error",
    "3821": "Non-responsive Error",
    "3823": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3824": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3825": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3828": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3829": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3832": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3833": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3834": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3838": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3841": "Non-responsive Error",
    "3842": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3843": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3845": "Non-responsive Error",
    "3847": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3848": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3849": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3852": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3860": "Non-responsive Error",
    "3862": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "3863": "Non-responsive Error",
    "3865": "Non-responsive Error",
    "3869": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3870": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3872": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3873": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3876": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3877": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3879": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3880": "Non-responsive Error",
    "3882": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3885": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3888": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3889": "Non-responsive Error",
    "3891": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3899": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3901": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3903": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3904": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3906": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3907": "Non-responsive Error",
    "3909": "Non-responsive Error",
    "3910": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "3911": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3912": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3913": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3916": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3917": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "3919": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3921": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3924": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3925": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3926": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3927": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3929": "Non-responsive Error",
    "3932": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3933": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3938": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3940": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3941": "Non-responsive Error",
    "3942": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3944": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3947": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3948": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3949": "Non-responsive Error",
    "3950": "Non-responsive Error",
    "3952": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3959": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3962": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3967": "Non-responsive Error",
    "3968": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3969": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3971": "Non-responsive Error",
    "3972": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3974": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3975": "Non-responsive Error",
    "3976": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3977": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3978": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3979": "Non-responsive Error",
    "3980": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3983": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3987": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3988": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3989": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3990": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3991": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3993": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "3995": "Non-responsive Error",
    "3997": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "3999": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4000": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4004": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4005": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4007": "Non-responsive Error",
    "4008": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4013": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4017": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4018": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4019": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4022": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4026": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4027": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4030": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4034": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4037": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4038": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4039": "Non-responsive Error",
    "4042": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4043": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4045": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4046": "Non-responsive Error",
    "4049": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4052": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4053": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4058": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4059": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4063": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4064": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4066": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4067": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4068": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4070": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4072": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4074": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4075": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4076": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4077": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4079": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4081": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4082": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4083": "Non-responsive Error",
    "4085": "Non-responsive Error",
    "4092": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4094": "Non-responsive Error",
    "4095": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4098": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4099": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4100": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4102": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4106": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4110": "Non-responsive Error",
    "4111": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4112": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4116": "Non-responsive Error",
    "4118": "Non-responsive Error",
    "4123": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4127": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4129": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4130": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4133": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4134": "Non-responsive Error",
    "4135": "Non-responsive Error",
    "4137": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4140": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4142": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4144": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4145": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4148": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4149": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4151": "Non-responsive Error",
    "4152": "Non-responsive Error",
    "4154": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4158": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4160": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4167": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4169": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4174": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4175": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4177": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4178": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4181": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4182": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4183": "Non-responsive Error",
    "4185": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4189": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4191": "Non-responsive Error",
    "4192": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4193": "Non-responsive Error",
    "4194": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4196": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4199": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4202": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4210": "Non-responsive Error",
    "4212": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4213": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4214": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4215": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4219": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4220": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4223": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4225": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4226": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4228": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4229": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4231": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "4233": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4234": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4236": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4238": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4242": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4243": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4244": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4246": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4254": "Non-responsive Error",
    "4256": "Non-responsive Error",
    "4258": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4261": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4263": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4273": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4274": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4275": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4276": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4277": "Non-responsive Error",
    "4278": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4281": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4282": "Non-responsive Error",
    "4283": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4284": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4285": "Non-responsive Error",
    "4287": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4290": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4291": "Non-responsive Error",
    "4293": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4294": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4295": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4296": "Non-responsive Error",
    "4298": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4299": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4304": "Non-responsive Error",
    "4305": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4311": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4312": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4313": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4316": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4317": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4318": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4322": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4325": "Non-responsive Error",
    "4328": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4333": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4334": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4336": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4337": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4344": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4345": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4346": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4349": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4351": "Non-responsive Error",
    "4353": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4355": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4357": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4358": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4359": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4366": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4368": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4369": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4371": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4373": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4374": "Non-responsive Error",
    "4375": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4376": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4379": "Non-responsive Error",
    "4380": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4381": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4385": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4389": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4391": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4392": "Non-responsive Error",
    "4394": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4396": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4398": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4399": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4401": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4402": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4405": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4406": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4408": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4411": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4412": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4414": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4416": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4417": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4418": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4422": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4428": "Non-responsive Error",
    "4429": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have metastatic lesions based on the information in the patient note.",
    "4434": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4435": "Non-responsive Error",
    "4436": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4437": "Non-responsive Error",
    "4439": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4440": "Non-responsive Error",
    "4441": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4442": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4443": "Non-responsive Error",
    "4444": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4446": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4447": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4450": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4451": "Non-responsive Error",
    "4452": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4453": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4456": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4459": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4467": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4468": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4470": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4471": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4473": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4475": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4476": "Non-responsive Error",
    "4477": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4478": "Non-responsive Error",
    "4482": "Non-responsive Error",
    "4488": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4489": "Non-responsive Error",
    "4490": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4491": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4493": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4494": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4496": "Non-responsive Error",
    "4497": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4500": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4501": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4502": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4503": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4504": "Non-responsive Error",
    "4505": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4506": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4507": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4509": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4511": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4513": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4516": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4517": "Non-responsive Error",
    "4521": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4523": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4524": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4525": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4527": "Non-responsive Error",
    "4528": "Non-responsive Error",
    "4529": "Non-responsive Error",
    "4531": "Non-responsive Error",
    "4532": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4534": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4535": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4536": "Non-responsive Error",
    "4538": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4539": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4541": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4544": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4545": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4547": "Non-responsive Error",
    "4548": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4549": "Non-responsive Error",
    "4550": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4553": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4555": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4556": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4557": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4558": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4561": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4562": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4563": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4566": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4567": "Non-responsive Error",
    "4571": "Non-responsive Error",
    "4572": "Non-responsive Error",
    "4573": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4576": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4577": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4578": "Non-responsive Error",
    "4580": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4582": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4583": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4584": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4585": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4586": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4587": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4588": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4589": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4590": "Non-responsive Error",
    "4593": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4595": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4596": "Non-responsive Error",
    "4598": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4604": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4605": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4610": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4611": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4612": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4615": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4618": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4632": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "4635": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4637": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4638": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4639": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4640": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4642": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4644": "Non-responsive Error",
    "4646": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4647": "Non-responsive Error",
    "4649": "Non-responsive Error",
    "4651": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4654": "Non-responsive Error",
    "4655": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4659": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4660": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4661": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4662": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4665": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4666": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4668": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4669": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4670": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4671": "Non-responsive Error",
    "4673": "Non-responsive Error",
    "4674": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4677": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4678": "Non-responsive Error",
    "4679": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4680": "Non-responsive Error",
    "4681": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4682": "Non-responsive Error",
    "4683": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4685": "Non-responsive Error",
    "4688": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4689": "Non-responsive Error",
    "4691": "Non-responsive Error",
    "4692": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4693": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4695": "Non-responsive Error",
    "4698": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4700": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4701": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4702": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4704": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4705": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4709": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4712": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4713": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4714": "Non-responsive Error",
    "4715": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4716": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4720": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4723": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4724": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4731": "Non-responsive Error",
    "4732": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4733": "Non-responsive Error",
    "4734": "Non-responsive Error",
    "4735": "Non-responsive Error",
    "4736": "Non-responsive Error",
    "4738": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4740": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4742": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4744": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4746": "Non-responsive Error",
    "4751": "Non-responsive Error",
    "4754": "Non-responsive Error",
    "4756": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4758": "Non-responsive Error",
    "4759": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4760": "Non-responsive Error",
    "4764": "Non-responsive Error",
    "4765": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4766": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4767": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4768": "Non-responsive Error",
    "4769": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4772": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4773": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4774": "Non-responsive Error",
    "4779": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4785": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4786": "Non-responsive Error",
    "4789": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4790": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4792": "Non-responsive Error",
    "4795": "Non-responsive Error",
    "4797": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4803": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4805": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4810": "Non-responsive Error",
    "4811": "Non-responsive Error",
    "4812": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4813": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4815": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4816": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4822": "Non-responsive Error",
    "4824": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4828": "Non-responsive Error",
    "4832": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4833": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4835": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4837": "Non-responsive Error",
    "4838": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4839": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "4840": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4841": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4848": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4849": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4852": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4853": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4855": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4856": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4857": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4858": "Non-responsive Error",
    "4860": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4861": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4863": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4864": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4865": "Non-responsive Error",
    "4874": "Non-responsive Error",
    "4876": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4877": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4878": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4879": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4880": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4881": "Non-responsive Error",
    "4882": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4886": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "4887": "Non-responsive Error",
    "4889": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4892": "Non-responsive Error",
    "4893": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4895": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4896": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4897": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4898": "Non-responsive Error",
    "4901": "Non-responsive Error",
    "4908": "Non-responsive Error",
    "4909": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4912": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4914": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4915": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4918": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4920": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4922": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4923": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4927": "Non-responsive Error",
    "4929": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4930": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4931": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4937": "Non-responsive Error",
    "4941": "Non-responsive Error",
    "4943": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4946": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4947": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4948": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4949": "Non-responsive Error",
    "4950": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could indicate the presence of distant metastases, which is an exclusion criterion for the trial (\"Advanced local disease or distant metastases (stage III or IV)\").\n\nIf the metastatic lesions mentioned in the patient note refer to distant metastases, then the patient would be ineligible for the trial.\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible based on the exclusion criteria.",
    "4951": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4953": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4954": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4958": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4959": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4961": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4962": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4963": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4971": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4973": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4974": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4975": "Non-responsive Error",
    "4980": "Non-responsive Error",
    "4983": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4984": "Non-responsive Error",
    "4986": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4987": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4988": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "4992": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "4993": "Non-responsive Error",
    "4995": "Non-responsive Error",
    "4996": "Non-responsive Error",
    "4997": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5000": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5001": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5002": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5004": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5005": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5006": "Non-responsive Error",
    "5007": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5008": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5009": "Non-responsive Error",
    "5012": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5016": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5017": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5018": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5019": "Non-responsive Error",
    "5021": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5023": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5024": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5026": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5028": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5029": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5031": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5036": "Non-responsive Error",
    "5037": "Non-responsive Error",
    "5039": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5040": "Non-responsive Error",
    "5041": "Non-responsive Error",
    "5042": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5044": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5046": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5047": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5049": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5050": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5054": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5055": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5056": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5059": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5061": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5063": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5066": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5067": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5068": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5072": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5073": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5074": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5077": "Non-responsive Error",
    "5078": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5080": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5081": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5082": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5085": "Non-responsive Error",
    "5086": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5091": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5092": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5093": "Non-responsive Error",
    "5094": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5095": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5097": "Non-responsive Error",
    "5098": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5099": "Non-responsive Error",
    "5101": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5102": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5104": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5105": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5106": "Non-responsive Error",
    "5107": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5108": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5109": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5113": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5117": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5118": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5120": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5121": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5122": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5123": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5124": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5127": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5128": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5131": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5132": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5133": "Non-responsive Error",
    "5135": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5139": "Non-responsive Error",
    "5140": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5142": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5144": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5146": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5147": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5150": "Non-responsive Error",
    "5151": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5152": "Non-responsive Error",
    "5153": "Non-responsive Error",
    "5155": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5157": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5158": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have metastatic lesions based on the information in the patient note.",
    "5159": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5160": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5163": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5164": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5169": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5171": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5172": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5173": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5176": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5178": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5179": "Non-responsive Error",
    "5181": "Non-responsive Error",
    "5182": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5183": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5184": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5185": "Non-responsive Error",
    "5189": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5193": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5194": "Non-responsive Error",
    "5195": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5199": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5200": "Non-responsive Error",
    "5202": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5203": "Non-responsive Error",
    "5205": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5207": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5208": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5211": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5212": "Non-responsive Error",
    "5213": "Non-responsive Error",
    "5214": "Non-responsive Error",
    "5218": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5220": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5221": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5222": "Non-responsive Error",
    "5224": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5226": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5227": "Non-responsive Error",
    "5228": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5229": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5230": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5231": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5232": "Non-responsive Error",
    "5233": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5235": "Non-responsive Error",
    "5237": "Non-responsive Error",
    "5239": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5242": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5246": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5248": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5250": "Non-responsive Error",
    "5253": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5254": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5255": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5256": "Non-responsive Error",
    "5258": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5259": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5261": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5263": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5264": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5265": "Non-responsive Error",
    "5267": "Non-responsive Error",
    "5268": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5270": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5272": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5275": "Non-responsive Error",
    "5280": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5283": "Non-responsive Error",
    "5284": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5285": "Non-responsive Error",
    "5286": "Non-responsive Error",
    "5288": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5289": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5290": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5293": "Non-responsive Error",
    "5295": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5296": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5297": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5298": "Non-responsive Error",
    "5301": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5302": "Non-responsive Error",
    "5303": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5306": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5307": "Non-responsive Error",
    "5310": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5311": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5312": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5313": "Non-responsive Error",
    "5314": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5316": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5317": "Non-responsive Error",
    "5318": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5319": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5321": "Non-responsive Error",
    "5322": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5323": "Non-responsive Error",
    "5325": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5326": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5329": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5330": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5332": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5334": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5337": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5340": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5341": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5342": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5345": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5347": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5351": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5353": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5354": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5356": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5357": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5358": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5359": "Non-responsive Error",
    "5360": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5363": "Non-responsive Error",
    "5364": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5368": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5371": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5378": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5380": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5381": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5382": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5383": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5384": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5387": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5388": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5389": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5394": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5403": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5407": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5409": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5411": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5414": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5415": "Non-responsive Error",
    "5416": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5417": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5419": "Non-responsive Error",
    "5420": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5421": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5423": "Non-responsive Error",
    "5425": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5429": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5431": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5433": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5435": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5436": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5437": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5440": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5441": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5446": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5449": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5450": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5453": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5454": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5457": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5458": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "5459": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "5460": "Non-responsive Error",
    "5463": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5464": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5467": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5468": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5469": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5471": "Non-responsive Error",
    "5475": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5478": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5479": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5480": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5481": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5483": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5487": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5488": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5489": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5491": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5493": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5494": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5495": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5497": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5499": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5500": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5502": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5503": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5504": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5507": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5509": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5510": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5511": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5514": "Non-responsive Error",
    "5515": "Non-responsive Error",
    "5516": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5517": "Non-responsive Error",
    "5519": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5520": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5522": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5527": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5529": "Non-responsive Error",
    "5531": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5532": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5533": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5535": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5536": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5538": "Non-responsive Error",
    "5539": "Non-responsive Error",
    "5540": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5541": "Non-responsive Error",
    "5543": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5544": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5545": "Non-responsive Error",
    "5546": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5550": "Non-responsive Error",
    "5551": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5553": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5555": "Non-responsive Error",
    "5557": "Non-responsive Error",
    "5559": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5562": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5563": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5565": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5566": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5567": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5569": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5577": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5590": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5592": "Non-responsive Error",
    "5594": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5597": "Non-responsive Error",
    "5599": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5605": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5607": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5612": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5619": "Non-responsive Error",
    "5626": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5630": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5632": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5633": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5634": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5641": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5644": "Non-responsive Error",
    "5645": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5648": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5653": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5656": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5659": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5662": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5664": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5668": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5669": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5673": "Non-responsive Error",
    "5675": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5676": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5678": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5679": "Non-responsive Error",
    "5680": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5685": "Non-responsive Error",
    "5687": "Non-responsive Error",
    "5689": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5691": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5696": "Non-responsive Error",
    "5698": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5702": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5703": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5704": "Non-responsive Error",
    "5708": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5711": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "5712": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5714": "Non-responsive Error",
    "5718": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5719": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5721": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5723": "Non-responsive Error",
    "5726": "Non-responsive Error",
    "5727": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5730": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5737": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5738": "Non-responsive Error",
    "5739": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5741": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5742": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5746": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5748": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5750": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5751": "Non-responsive Error",
    "5757": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5759": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5760": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5767": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5769": "Non-responsive Error",
    "5770": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5775": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5776": "Non-responsive Error",
    "5778": "Non-responsive Error",
    "5783": "Non-responsive Error",
    "5785": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5789": "Non-responsive Error",
    "5791": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5793": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5794": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5797": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5798": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5801": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5805": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "5806": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5810": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5811": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "5814": "Non-responsive Error",
    "5819": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5820": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5821": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5830": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5831": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5833": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5837": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5844": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5846": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5847": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5849": "Non-responsive Error",
    "5850": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5851": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5853": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5854": "Non-responsive Error",
    "5857": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5858": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5859": "Non-responsive Error",
    "5861": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5864": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5870": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5871": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5872": "Non-responsive Error",
    "5874": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5875": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5876": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5877": "Non-responsive Error",
    "5880": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5881": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5885": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5893": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5894": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5898": "Non-responsive Error",
    "5899": "Non-responsive Error",
    "5903": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5906": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5907": "Non-responsive Error",
    "5910": "Non-responsive Error",
    "5911": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5913": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5915": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5917": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5918": "Non-responsive Error",
    "5919": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5920": "Non-responsive Error",
    "5922": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5926": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5928": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5934": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5935": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5936": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5938": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5940": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5941": "Non-responsive Error",
    "5943": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5946": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5952": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5954": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5955": "Non-responsive Error",
    "5956": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5960": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "5965": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5968": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5969": "Non-responsive Error",
    "5973": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5974": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5975": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5977": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5978": "Non-responsive Error",
    "5979": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5981": "Non-responsive Error",
    "5984": "Non-responsive Error",
    "5985": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5991": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "5992": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5993": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5995": "Non-responsive Error",
    "5998": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "5999": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6003": "Non-responsive Error",
    "6004": "Non-responsive Error",
    "6006": "Non-responsive Error",
    "6010": "Non-responsive Error",
    "6012": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6014": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6017": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6019": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6020": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6021": "Non-responsive Error",
    "6025": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6030": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6031": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6033": "Non-responsive Error",
    "6034": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6035": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6041": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6043": "Non-responsive Error",
    "6044": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6045": "Non-responsive Error",
    "6049": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6054": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6056": "Non-responsive Error",
    "6061": "Non-responsive Error",
    "6062": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6064": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6065": "Non-responsive Error",
    "6068": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6069": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6070": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6072": "Non-responsive Error",
    "6073": "Non-responsive Error",
    "6074": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6076": "Non-responsive Error",
    "6077": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6080": "Non-responsive Error",
    "6081": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6084": "Non-responsive Error",
    "6087": "Non-responsive Error",
    "6088": "Non-responsive Error",
    "6090": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6096": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6097": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6099": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6102": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6103": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6105": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6108": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6111": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6112": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6115": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6117": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6118": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6119": "Non-responsive Error",
    "6122": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6123": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6125": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6128": "Non-responsive Error",
    "6133": "Non-responsive Error",
    "6134": "Non-responsive Error",
    "6135": "Non-responsive Error",
    "6138": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6143": "Non-responsive Error",
    "6147": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6148": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6149": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6151": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6157": "Non-responsive Error",
    "6161": "Non-responsive Error",
    "6162": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6163": "Non-responsive Error",
    "6164": "Non-responsive Error",
    "6166": "Non-responsive Error",
    "6170": "Non-responsive Error",
    "6171": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6175": "Non-responsive Error",
    "6177": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6178": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6180": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6186": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6188": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6191": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6193": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6196": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6198": "Non-responsive Error",
    "6199": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6200": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6201": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6202": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6203": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6204": "Non-responsive Error",
    "6205": "Non-responsive Error",
    "6206": "Non-responsive Error",
    "6208": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6210": "Non-responsive Error",
    "6211": "Non-responsive Error",
    "6213": "Non-responsive Error",
    "6214": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6215": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6216": "Non-responsive Error",
    "6217": "Non-responsive Error",
    "6223": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6225": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6228": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6229": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6232": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6233": "Non-responsive Error",
    "6235": "Non-responsive Error",
    "6237": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6241": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6242": "Non-responsive Error",
    "6244": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6249": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6250": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6254": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6255": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "6258": "Non-responsive Error",
    "6264": "Non-responsive Error",
    "6265": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6266": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6267": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6268": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6270": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6271": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6273": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6276": "Non-responsive Error",
    "6283": "Non-responsive Error",
    "6284": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6286": "Non-responsive Error",
    "6289": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "6290": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6292": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6293": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6294": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6295": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6297": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6299": "Non-responsive Error",
    "6300": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6303": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6304": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6305": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6308": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6311": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6312": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6313": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6316": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6317": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6319": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6320": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6321": "Non-responsive Error",
    "6323": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6326": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6327": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6331": "Non-responsive Error",
    "6332": "Non-responsive Error",
    "6333": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6334": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6336": "Non-responsive Error",
    "6337": "Non-responsive Error",
    "6340": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6345": "Non-responsive Error",
    "6346": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6347": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6348": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6350": "Non-responsive Error",
    "6354": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6361": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6362": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6363": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6365": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6366": "Non-responsive Error",
    "6369": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6370": "Non-responsive Error",
    "6372": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6374": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6375": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6376": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6379": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6383": "Non-responsive Error",
    "6384": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6385": "Non-responsive Error",
    "6388": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6390": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6391": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6393": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6395": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6396": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6397": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6399": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6402": "Non-responsive Error",
    "6403": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6404": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6408": "Non-responsive Error",
    "6414": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6415": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6418": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6425": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6427": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6429": "Non-responsive Error",
    "6434": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6436": "Non-responsive Error",
    "6444": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6446": "Non-responsive Error",
    "6449": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6452": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6453": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6454": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6462": "Non-responsive Error",
    "6463": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6467": "Non-responsive Error",
    "6471": "Non-responsive Error",
    "6472": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6476": "Non-responsive Error",
    "6482": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6484": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6485": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6490": "Non-responsive Error",
    "6491": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6495": "Non-responsive Error",
    "6499": "Non-responsive Error",
    "6503": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6506": "Non-responsive Error",
    "6509": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6510": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6520": "Non-responsive Error",
    "6529": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6534": "Non-responsive Error",
    "6537": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6539": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6542": "Non-responsive Error",
    "6545": "Non-responsive Error",
    "6556": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6559": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6566": "Non-responsive Error",
    "6574": "Non-responsive Error",
    "6576": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6577": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6585": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6588": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6591": "Non-responsive Error",
    "6597": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6598": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6599": "Non-responsive Error",
    "6603": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6607": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6609": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6615": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6616": "Non-responsive Error",
    "6618": "Non-responsive Error",
    "6628": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6629": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6630": "Non-responsive Error",
    "6632": "Non-responsive Error",
    "6633": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6634": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6638": "Non-responsive Error",
    "6640": "Non-responsive Error",
    "6644": "Non-responsive Error",
    "6646": "Non-responsive Error",
    "6647": "Non-responsive Error",
    "6650": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6651": "Non-responsive Error",
    "6655": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6660": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6661": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6662": "Non-responsive Error",
    "6664": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6669": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6670": "Non-responsive Error",
    "6677": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6678": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6680": "Non-responsive Error",
    "6681": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6682": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6686": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6687": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6688": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6690": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6696": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6698": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6701": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6702": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6709": "Non-responsive Error",
    "6711": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6714": "Non-responsive Error",
    "6720": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6725": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6726": "Non-responsive Error",
    "6729": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6733": "Non-responsive Error",
    "6735": "Non-responsive Error",
    "6738": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6741": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6742": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6744": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6747": "Non-responsive Error",
    "6750": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6751": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6752": "Non-responsive Error",
    "6755": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6758": "Non-responsive Error",
    "6769": "Non-responsive Error",
    "6771": "Non-responsive Error",
    "6772": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6773": "Non-responsive Error",
    "6790": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6791": "Non-responsive Error",
    "6795": "Non-responsive Error",
    "6798": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6799": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6800": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6803": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6804": "Non-responsive Error",
    "6814": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6818": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6820": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6821": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6827": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6828": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6844": "Non-responsive Error",
    "6853": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6855": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6862": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6866": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6868": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6871": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6872": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6873": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6875": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "6878": "Non-responsive Error",
    "6880": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6883": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6884": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6885": "Non-responsive Error",
    "6886": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6887": "Non-responsive Error",
    "6889": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6890": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6891": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6893": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6897": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6900": "Non-responsive Error",
    "6902": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6903": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6906": "Non-responsive Error",
    "6910": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6916": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6918": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6921": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6926": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6927": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6928": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6929": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6930": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6932": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6933": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6935": "Non-responsive Error",
    "6938": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6939": "Non-responsive Error",
    "6941": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6942": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6944": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6947": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6948": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6950": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6951": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6952": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6953": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6954": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6955": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6957": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6959": "Non-responsive Error",
    "6961": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6963": "Non-responsive Error",
    "6965": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient note mentions \"CXR was remarkable for metastatic lesions\". This could potentially indicate distant metastases (stage IV disease), which is an exclusion criterion for the trial.\n\nIf the \"metastatic lesions\" refer to distant metastases, then the patient would be ineligible for the trial due to the exclusion criteria of \"Advanced local disease or distant metastases (stage III or IV)\".\n\nReason type: [2]\n\nThe model may have hallucinated or missed the information about potential distant metastases in the patient note, which could make the patient ineligible for the trial.",
    "6968": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6974": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6975": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6976": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6977": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6980": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6981": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6982": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6984": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6985": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6986": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6987": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "6988": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6990": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6991": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "6993": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "6994": "Non-responsive Error",
    "6999": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7000": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7001": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7003": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7004": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7005": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7006": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7007": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7008": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7009": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7010": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7011": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7012": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7013": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7017": "Non-responsive Error",
    "7019": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7021": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7025": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7028": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7029": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7032": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7033": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "7034": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7035": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "7036": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7037": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7042": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7044": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7046": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7047": "Non-responsive Error",
    "7049": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7051": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7052": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7053": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7055": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7056": "Non-responsive Error",
    "7060": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7062": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7064": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7066": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7068": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7069": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7070": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7072": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7075": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7077": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7078": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7080": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7082": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7083": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7085": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "7086": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7090": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7091": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have metastatic lesions based on the information in the patient note.",
    "7092": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7098": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7099": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7100": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7102": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7105": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7107": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7108": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7110": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7111": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7112": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have hallucinated or overlooked the information about metastatic lesions in the patient note, which could make the patient ineligible if it indicates advanced or metastatic disease.",
    "7113": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7114": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7117": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7118": "Non-responsive Error",
    "7128": "Non-responsive Error",
    "7130": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7134": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7135": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7136": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7137": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7141": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7146": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7147": "Non-responsive Error",
    "7148": "Non-responsive Error",
    "7151": "Non-responsive Error",
    "7153": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7154": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7156": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7159": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7170": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7171": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7175": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7178": "Non-responsive Error",
    "7182": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7191": "Non-responsive Error",
    "7192": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7197": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7201": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7202": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7203": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7206": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7207": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7212": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7213": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7214": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7215": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "7222": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7224": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7231": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "7232": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7235": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7239": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7240": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7242": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7244": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7245": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7247": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7250": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7251": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7252": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7254": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7255": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7256": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7257": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7258": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7260": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7261": "Non-responsive Error",
    "7264": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7268": "Non-responsive Error",
    "7269": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7271": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7272": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7273": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7280": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7281": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7284": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7288": "Non-responsive Error",
    "7289": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "7290": "Non-responsive Error",
    "7293": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7294": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7296": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7297": "Non-responsive Error",
    "7298": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7299": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7300": "Non-responsive Error",
    "7303": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7305": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7310": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7311": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7313": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7314": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7318": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7319": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7324": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7328": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7329": "Non-responsive Error",
    "7330": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7331": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7333": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7335": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7337": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7338": "Non-responsive Error",
    "7339": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7340": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7342": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7343": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7344": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7345": "Non-responsive Error",
    "7348": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7361": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7362": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7363": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets all the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7364": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) based on the presence of distant metastases mentioned in the patient note.",
    "7366": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7367": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7374": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7377": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7379": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7381": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7382": "Non-responsive Error",
    "7384": "Non-responsive Error",
    "7386": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7389": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7394": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7395": "Non-responsive Error",
    "7401": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7402": "Non-responsive Error",
    "7406": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7407": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7408": "Non-responsive Error",
    "7409": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7410": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7416": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7417": "Non-responsive Error",
    "7418": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7419": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7420": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial appears to be incorrect. The reason for the incorrect prediction is:\n\nReason type: [2]\n\nThe model hallucinated additional patient information that does not exist in the input patient note. Specifically, the patient note mentions that the CXR was \"remarkable for metastatic lesions\", which would indicate the presence of distant metastases (stage IV disease). However, the clinical trial's exclusion criteria explicitly state that patients with \"Advanced local disease or distant metastases (stage III or IV)\" will be excluded from the trial.\n\nTherefore, the model should have predicted the patient as ineligible (excluded) for the clinical trial based on the presence of distant metastases mentioned in the patient note.",
    "7421": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR.",
    "7424": "Based on the analysis, the model prediction that the patient is eligible for the clinical trial seems correct. The patient meets the inclusion criteria and does not have any of the exclusion criteria mentioned.\n\nHowever, there is one potential issue that the model may have missed - the patient's CXR was remarkable for metastatic lesions, which could indicate advanced disease or distant metastases (stage III or IV). If this is the case, the patient would be excluded from the trial according to the exclusion criteria.\n\nReason type: [2] - The model may have overlooked or hallucinated that the patient does not have distant metastases, which is contradicted by the information in the patient note about metastatic lesions on CXR."
}